Development of Novel Chemical Probes for Biological Applications

Lead Research Organisation: University of Strathclyde
Department Name: Pure and Applied Chemistry

Abstract

There is significant interest in tagging protein and peptide targets with a particular label in order to fully understand their role in disease. The application of such chemical tags is hampered by the paucity of methods that are available to conjugate these entities to target proteins in a controlled way. This collaborative effort, which is at the interface of chemistry and biology, centres around addressing the gap outlined above through the development of new conjugation chemistry using a hitherto underexploited reaction manifold, allowing for labelling of only acidic residues in a target protein using a photochemically generated reactive species. This project paves the way towards being able to develop new reagents for understanding protein function that can be combined with a biomolecule of interest in a predictable and selective manner. The general theme of the work is strongly aligned with a key growth area in the current EPSRC portfolio, specifically Chemical Biology. In addition, this proposal complements on-going research collaborations between GSK and the University of Strathclyde involving a wider programme of Industrial PhD students based in the GSK laboratories and funded by GSK.

Publications

10 25 50

Studentship Projects

Project Reference Relationship Related To Start End Student Name
EP/R512114/1 01/10/2017 31/12/2022
1974609 Studentship EP/R512114/1 01/10/2017 30/09/2021 Christopher Riley
 
Description This research has been entirely based around synthesis and biological testing of potential drug candidates for the treatment of castration-resistant prostate cancer (CRPC) through a novel mode of action.
Drug analogues have been synthesised and tested that display increased effectiveness and improved drug-like properties such as metabolic stability.
An excellent understanding of synthetic strategies towards molecules of interest has been developed.
A research collaboration between the university of Strathclyde and the university of Aberdeen has also been established.
Exploitation Route Future projects within the group, or myself in the later years of this project, may make further progress towards improving the drug candidate quality of the aforementioned molecules of interest for the treatment of CRPC. If publication(s) are generated then this work could be built upon by any other industrial or academic group looking to develop CRPC treatments.
Sectors Chemicals,Pharmaceuticals and Medical Biotechnology

 
Description Collaboration with the University of Aberdeen 
Organisation University of Aberdeen
Country United Kingdom 
Sector Academic/University 
PI Contribution I have been responsible for the synthesis of candidate drug molecules for biological testing in Aberdeen in cellular assays.
Collaborator Contribution The cellular assay based testing of all the compounds synthesised in Glasgow has been carried out by our collaborators at the university of Aberdeen.
Impact All potency data generated for the range of compounds synthesised is a result of this collaboration. This is a multidisciplinary collaboration including chemistry and biology.
Start Year 2018